{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:44:37Z","timestamp":1791186277415,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fondazione Anna Maria Sechi per il Cuore"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ijcard.2018.12.008","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T02:38:10Z","timestamp":1543891090000},"page":"55-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Anti-anginal drugs: Systematic review and clinical implications"],"prefix":"10.1016","volume":"283","author":[{"given":"Rita","family":"Pavasini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo G.","family":"Camici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Crea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Danchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios J.","family":"Manolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Marzilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe M.C.","family":"Rosano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Lopez-Sendon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Balla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"38","key":"10.1016\/j.ijcard.2018.12.008_bb0005","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.12.008_bb0010","unstructured":"2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. JACC.2012; 60:e44\u2013e164."},{"key":"10.1016\/j.ijcard.2018.12.008_bb0015","unstructured":"National Clinical Guidelines Centre. Stable Angina: Methods, Evidence & Guidance. NICE http:\/\/www.nice.org.uk\/guidance\/cg126\/evidence\/full-guideline-183176605 (2011)."},{"issue":"2","key":"10.1016\/j.ijcard.2018.12.008_bb0020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nrcardio.2017.131","article-title":"Expert consensus document: A \u2018diamond\u2019 approach to personalized treatment of angina","volume":"15","author":"Ferrari","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcard.2018.12.008_bb0025","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ijcard.2015.08.045","article-title":"Unresolved issues in the management of chronic stable angina","volume":"201","author":"Camm","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.12.008_bb0030","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1177\/2047487316648475","article-title":"Management of stable angina: a commentary on the European Society of Cardiology guidelines","volume":"23","author":"Ambrosio","year":"2016","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcard.2018.12.008_bb0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijcard.2016.06.150","article-title":"Medical treatment of stable angina: a tailored therapeutic approach","volume":"220","author":"Manolis","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.12.008_bb0040","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10557-016-6681-2","article-title":"Management of stable angina current guide lines: a critical appraisal","volume":"30","author":"Thadani","year":"2016","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ijcard.2018.12.008_bb0045","article-title":"Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment","volume":"27","author":"Ferrari","year":"2018","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcard.2018.12.008_bb0050","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40265-017-0691-7","article-title":"Drug therapy for stable angina pectoris","volume":"77","author":"Rousan","year":"2017","journal-title":"Drugs"},{"issue":"20","key":"10.1016\/j.ijcard.2018.12.008_bb0055","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/jama.281.20.1927","article-title":"Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina","volume":"281","author":"Heidenreich","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2018.12.008_bb0060","author":"Higgins"},{"key":"10.1016\/j.ijcard.2018.12.008_bb0065","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.ijcard.2018.12.008_bb0070","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/clc.4960231014","article-title":"Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris","volume":"23","author":"Pehrsson","year":"2000","journal-title":"Clin. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2018.12.008_bb0075","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000047392","article-title":"A double-blind, parallel-group study of amlodipine versus long-acting nitrate in the management of elderly patients with stable angina","volume":"96","author":"Hall","year":"2001","journal-title":"Cardiology"},{"issue":"6","key":"10.1016\/j.ijcard.2018.12.008_bb0080","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1253\/circj.71.826","article-title":"Double-blind, multicenter, active-controlled, randomized clinical trial to assess the safety and efficacy of orally administered nicorandil in patients with stable angina pectoris in China","volume":"71","author":"Zhu","year":"2007","journal-title":"Circ. J."},{"issue":"2","key":"10.1016\/j.ijcard.2018.12.008_bb0085","first-page":"213","article-title":"Comparison of the antiischaemic and antianginal effects of nicorandil and amlodipine in patients with symptomatic stable angina pectoris: the SWAN study","volume":"2","author":"Chatterjee","year":"1999","journal-title":"J. Clin. Basic Cardiol."},{"issue":"Suppl B","key":"10.1016\/j.ijcard.2018.12.008_bb0090","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/eurheartj\/14.suppl_B.30","article-title":"A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris","volume":"14","author":"Guermonprez","year":"1993","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.12.008_bb0095","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.amjcard.2004.09.025","article-title":"Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris","volume":"95","author":"Rousseau","year":"2005","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2018.12.008_bb0100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2125.1994.tb04276.x","article-title":"Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group","volume":"37","author":"Detry","year":"1994","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.ijcard.2018.12.008_bb0105","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2143\/AC.59.6.2005248","article-title":"Comparison of the effects of trimetazidine and diltiazem on exercise performance in patients with coronary heart disease. The Turkish trimetazidine study (TTS)","volume":"59","author":"Koylan","year":"2004","journal-title":"Acta Cardiol."},{"issue":"23","key":"10.1016\/j.ijcard.2018.12.008_bb0110","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/eurheartj\/ehi586","article-title":"Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina","volume":"26","author":"Tardif","year":"2005","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.ijcard.2018.12.008_bb0115","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/pds.3628","article-title":"The efficacy and safety of ivabradine hydrochloride versus atenolol in Chinese patients with chronic stable angina pectoris","volume":"23","author":"Li","year":"2014","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"3","key":"10.1016\/j.ijcard.2018.12.008_bb0120","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2165\/00003495-200767030-00005","article-title":"Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial","volume":"67","author":"Ruzyllo","year":"2007","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.ijcard.2018.12.008_bb0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/eurheartj\/ehx564","article-title":"Beta-blockers in heart failure collaborative group. Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials","volume":"39","author":"Cleland","year":"2018","journal-title":"Eur. Heart J."}],"updated-by":[{"DOI":"10.1016\/j.ijcard.2020.06.028","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:00:00Z","timestamp":1607990400000}}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318360947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318360947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T09:44:27Z","timestamp":1668591867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318360947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":25,"alternative-id":["S0167527318360947"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.12.008","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ijcard.2020.06.028","asserted-by":"object"}]},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-anginal drugs: Systematic review and clinical implications","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}